![Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward - American Journal of Kidney Diseases Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward - American Journal of Kidney Diseases](https://www.ajkd.org/cms/asset/d5d8b387-db33-4076-a3b5-a06f67794dbb/gr1.jpg)
Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward - American Journal of Kidney Diseases
![Treatment strategy for patients with hepatorenal syndrome. Terlipressin... | Download Scientific Diagram Treatment strategy for patients with hepatorenal syndrome. Terlipressin... | Download Scientific Diagram](https://www.researchgate.net/publication/49716638/figure/fig3/AS:277027514011684@1443059915027/Treatment-strategy-for-patients-with-hepatorenal-syndrome-Terlipressin-is-widely-used-in.png)
Treatment strategy for patients with hepatorenal syndrome. Terlipressin... | Download Scientific Diagram
![Continuous terlipressin infusion is associated with improved diet intake and muscle strength in patients awaiting liver transplant - ScienceDirect Continuous terlipressin infusion is associated with improved diet intake and muscle strength in patients awaiting liver transplant - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589555919300357-ga1.jpg)
Continuous terlipressin infusion is associated with improved diet intake and muscle strength in patients awaiting liver transplant - ScienceDirect
![Management of hepatorenal syndrome in liver cirrhosis: a recent update - Chinmay Bera, Florence Wong, 2022 Management of hepatorenal syndrome in liver cirrhosis: a recent update - Chinmay Bera, Florence Wong, 2022](https://journals.sagepub.com/cms/10.1177/17562848221102679/asset/images/large/10.1177_17562848221102679-fig2.jpeg)
Management of hepatorenal syndrome in liver cirrhosis: a recent update - Chinmay Bera, Florence Wong, 2022
![Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized Study - ScienceDirect Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508508002527-gr1.jpg)
Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized Study - ScienceDirect
![Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older | Annals of Hepatology Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older | Annals of Hepatology](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//16652681/0000002800000005/v1_202308301015/S1665268123002302/v1_202308301015/en/main.assets/ga1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w96p5LBcBpyJTqfwgorxm+Ow=)
Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older | Annals of Hepatology
![Management of Hepatorenal Syndrome in the Era of Acute-on-Chronic Liver Failure: Terlipressin and Beyond - Gastroenterology Management of Hepatorenal Syndrome in the Era of Acute-on-Chronic Liver Failure: Terlipressin and Beyond - Gastroenterology](https://www.gastrojournal.org/cms/asset/cde7ae94-ec46-4e0c-90de-99df5461ed2f/gr1.jpg)
Management of Hepatorenal Syndrome in the Era of Acute-on-Chronic Liver Failure: Terlipressin and Beyond - Gastroenterology
![Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile - ScienceDirect Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661816304741-fx1.jpg)